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Background: Improving survival from gynaecological cancers is creating an increasing clinical 
challenge for long-term distress management. Psychologist-led interventions for cancer survivors 
can be beneficial, but are often costly. The rise of the Psychological Wellbeing Practitioner (PWP) 
workforce in the UK might offer a cheaper, but equally effective, intervention delivery method that 
is more sustainable and accessible. We aimed to test the effectiveness of a PWP co-facilitated 
intervention for reducing depression and anxiety, quality of life and unmet needs.  
Methods: We planned this trial using a pragmatic, non-randomised controlled design, recruiting a 
comparator sample from a second clinical site. The intervention was delivered over six-weekly 
sessions; data were collected from participants at baseline, weekly during the intervention, and at 
one-week and three-month follow-up. Logistical challenges meant that we only recruited 8 
participants to the intervention group, and 26 participants to the control group. 
Results: We did not find significant, between-group differences for depression, quality of life or 
unmet needs, though some differences at follow-up were found for anxiety (p<.001). Analysis of 
potential intervention mediator processes indicated the potential importance of self-management 
self-efficacy. Low uptake into the psychological intervention raises questions about (a) patient-
driven needs for group-based support, and (b) the sustainability of this intervention programme. 
Conclusions: This study failed to recruit to target; the under-powered analysis likely explains the lack 
of significant effects reported, though some trends in the data are of interest. Retention in the 
intervention group, and low attrition in the control group indicate acceptability of the intervention 
content and trial design; however a small baseline population rendered this trial infeasible in its 
current design. Further work is required to answer our research questions, but also, importantly, to 
address low uptake for psychological interventions in this group of cancer survivors.  
Trial registration: ClinicalTrials.gov, NCT03553784 (registered 14 June 2018). 
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Plain Language Summary 
An increasing number of people are surviving for longer time periods following treatment for 
gynaecological cancer and this means we need to change how we care for and support a growing 
cancer survivor population. Psychological distress and poor quality of life are common in people 
affected by cancer, and these do not always improve once treatment ends. Providing psychological 
support can be expensive, which means that not everyone who wants it can access it. Psychological 
Wellbeing Practitioners (PWPs) have been introduced in UK health care. This workforce might offer 
an alternative for providing psychological support to a greater number of cancer survivors.  
We aimed to test how good a PWP co-delivered intervention is at improving depression, anxiety and 
quality of life in people who had been treated for gynaecological cancer. The intervention was 
delivered to small groups of patients over six weekly sessions. We compared those who received the 
intervention with a similar patient group who did not have access to the same psychological support 
from a different hospital. Participants reported their psychological wellbeing and quality of life at the 
point of recruitment, weekly for six weeks, and then at follow-up time-points one week and three 
months later.  
Because of low interest in the group intervention we did not recruit to target. Only 8 participants 
took part in the intervention, and we recruited only 26 participants in the control group. This means 
we can’t have full confidence in our results. Nonetheless, the findings indicate that this intervention 
was helpful for improving participants’ anxiety levels.  
Further trials, which recruit a larger number of cancer survivors, are needed to answer our research 
questions. However, this trial indicates acceptability and potential benefit. We also need to 
undertake research to understand why so few cancer survivors wanted to take part in this group-





Gynaecological cancers (cervical, ovarian, uterine, vaginal and vulvar) accounted for 5.9% (18,026) of 
all England-based cancer registrations in 2017 [1]. Many gynaecological cancers are associated with 
improving survival rates [2]; however, ovarian cancer, has one of the smallest increases in one- and 
five-year survival rates compared to other cancer types [3]. Delay to diagnosis from first symptom 
presentation is often longer in cervical cancer than other more common cancers [4] which may be 
contributory to comparatively smaller increased in overall survival [5]. Greater diagnostic delay can 
also lead to psychological distress [6], an important outcome which is understood to be predictive of 
survival in some cancer groups [7]. Information on the unmet psychological and supportive care 
needs of women with gynaecological cancer is limited, particularly comparisons between sub-types 
of gynaecological diagnosis, and especially in relation to concurrent psychological distress [8.9]. 
Recent research suggests increased fear of recurrence [10] and sexuality needs [11] may be 
particularly problematic for this group.  Beesley et al’s systematic review [12] suggested that psycho-
education may be helpful in supporting gynaecological cancer survivors to manage some late 
treatment effects; however, more data is needed on the beneficial impacts of psychological 
treatment on quality of life in people affected by gynaecological cancer [13].  
Increasing evidence suggests that psychosocial interventions are beneficial in reducing distress in 
adults with cancer [14]. Cognitive Behavioural Therapy (CBT) currently enjoys the strongest 
evidence-base for psychological distress in people affected by cancer [15] including interventions 
which aim to improve anxiety, depression and quality of life [16,17]. Concerns remain regarding the 
generalisability of findings due to small sample sizes used; Xiao et al [17] and Hulbert-Williams et al 
[15], for example, emphasise the need for further well-designed and better powered randomised 
controlled trials to improve the evidence base for psychological interventions in those affected by 
cancer.  
In gynaecological cancers specifically, the evidence is somewhat less conclusive. Beesley et al.’s 
systematic review, concluded that counselling-based approaches improve psychological wellbeing 
for women with gynaecological cancer [18]. Further, Rost et al.’s comparison of Acceptance and 
Commitment Therapy (ACT) and CBT for women with advanced ovarian cancer reported improved 
mood and quality of life in both groups [19]. Other studies have shown that interventions to increase 
physical activity can reduce fatigue [20] and when combined with CBT, improve quality of life in 
addition to physical health [21]. Mindfulness-based interventions have shown promising evidence 
for improved sexual functioning in those with ovarian cancer [22]. Null findings for the evidence of 
psychological intervention in this group have also been reported, however. For example, Chan et 
al.’s randomised controlled trial of CBT-based psychoeducation, stress management, relaxation, and 
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pain and distress management reported no significant effect on quality of life or distress compared 
with treatment as usual control group receiving routine medical care [23]. Chan et al. postulate that 
the lack of significant effects may have resulted from the decision not to screen participants for high 
distress which may have diluted the effect of the intervention, and other authors have noted this as 
a broader methodological problem in psychosocial oncology intervention science [15].   
To maximise potential for implementation into standard care, there is a need for trials of 
psychological interventions that demonstrate not only evidence for improved outcomes, but also 
cost- and service-effectiveness too [24]. Traditional psychological interventions are typically 
delivered by a small number of trained therapists [25] and tend to be time-intensive [26]. The cost of 
training, the shortfall of qualified therapists, and the increasing demand for psychological 
interventions that comes with improved cancer survival rates are making the current service delivery 
model potentially untenable for long-term sustainability. As such, there a need for the development 
of more cost-effective delivery models, including those which can be delivered by non-psychologist 
members of the existing healthcare team.  
For some years, the English National Health Service (NHS) has provided the delivery of brief 
psychological services by a specially trained workforce of psychological wellbeing practitioners 
(PWPs) as part a stepped-care model within the Improving Access to Psychological Therapies (IAPT) 
initiative [27]. Although some questions remain about the overall effectiveness of PWPs [28], this 
model is attractive because of cost-effectiveness potential: by providing lower-intensity, briefer 
interventions before symptoms escalate in severity, PWPs can have higher caseloads allowing 
increased access treatment [29]. Training is also less exhaustive than for other psychological 
specialists offering potential cost-savings there too. The 2016 NHS Five Year Forward View for 
Mental Health [30], suggests that two-thirds of the increase in target access figures for IAPT will be 
in individuals with co-morbid physical and mental health conditions. This has acted as a catalyst to 
expand the PWP role to include service provision for people with chronic health conditions, including 
cancer.   
An additional cost-benefit element of IAPT services is achieved because of the option for a group-
based delivery model [29], which is also commonplace in cancer care, including in the delivery of 
CBT-based psychological interventions [31,32]. A recent systematic review of psychotherapeutic 
interventions for women with metastatic breast cancer concluded that whilst group-based 
interventions have the strongest evidence or efficacy, they also suffer from some of the lowest 
uptake and adherence [33]. Outside of cancer care, research has compared individual versus group 
delivery of CBT in chronic health settings, finding that group-based delivery leads to greater 
treatment improvement and satisfaction [34]. Qualitative evaluation of a psychoeducation and 
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counselling group intervention for post-treatment gynaecological cancer survivors suggests that 
positive impacts were related to the “… special community of mutual understanding and belonging” 
that is created [35].  
Study aims 
Stepped-care models such as that used in the IAPT service are recognised as essential parts of good 
clinical psychosocial cancer care [36], but given the changing context in UK-based mental health 
care, research which explores the efficacy of PWP-supported service delivery on cancer outcomes is 
needed. Our study reports on a trial of a group-based, CBT intervention for gynaecological cancer 
survivors that was designed around incorporation of PWPs as co-facilitators. Our primary aim was to 
explore effectiveness in improving depression and anxiety against a non-randomised control group. 
As secondary aims, we wanted to test: (a) intervention effects on quality of life and unmet needs, 
and (b) potential mediators of intervention outcomes.  
Although originally planned as a full clinical trial, recruitment difficulties at both our intervention and 
control site meant that we had to stop the trial short of our recruitment targets. Our paper reports 
both our originally intended design and adjustments made in relation to our recruitment difficulties. 
We include discussion of learning points related to this which should be considered in planning 
similar trails elsewhere. 
 
Methods 
This trial has been registered at ClinicalTrials.gov (NCT03553784; registered 14 June 2018). The full 
trial protocol is available on the Open Science Framework (DOI 10.17605/OSF.IO/YGHNE). 
Design and setting 
This study employed a non-randomised controlled trial design. The intervention group were 
recruited from a gynaecology-specific psycho-oncology service in England, where the intervention is 
delivered as part of standard care. A pragmatic non-randomised treatment-as-usual control group 
were recruited from a different clinical setting (North Wales). A fully randomized design was not 
possible because (a) there was yet no evidence base to roll-out the intervention for delivery at this 
second recruitment site, and (b) because a single-site randomized trial would have necessitated 
withholding a standard-care intervention from patients randomized to the control group, which 
would have raised considerable ethical and logistical concerns [37]. Pragmatic trial designs [38], 
where data collection has to complement current clinical delivery, are increasingly being used.  
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The intervention clinical team in the East of England were members of a pilot psycho-oncology 
service funded by a combination of third sector and local NHS awards. The service was designed to 
deliver an integrated psychological care model to patients with gynaecological cancers attending a 
large regional teaching hospital for treatment. The hospital provides comprehensive cancer care to 
patients both in the county in which it is located, and to out of county patients as a tertiary referral 
centre. The service was funded to see patients both in outpatient and inpatient settings and was 
located on the hospital site within the hospital’s department of psychological medicine. 
This study was reviewed by the University of Chester Department of Psychology Ethics Committee 
and was formally approved by the North Wales Research Ethics Committee (REC-4) (Reference: 
18/WA/0079; IRAS Project ID: 239518). Health Research Authority permissions were approved at 
each clinical site. Written informed consent was obtained from all participants to take part in the 
trial. 
The intervention  
The intervention is a group-delivered, low-intensity CBT-based course that is offered as part of 
standard care to people diagnosed with gynaecological cancer across hospitals in the East Anglia 
region of England. The content broadly includes: (i) psychoeducation about the emotional impact of 
cancer survivorship; (ii) values-based behavioural activation; (iii) thought challenging negative and 
problematic cognitions; (iv) coping with uncertainty; (v) narrative therapy-based approaches to 
supporting identity concerns; and (vi) psycho-education about sleep hygiene and fatigue. The 
content of the intervention was not altered by the study protocol as our aim was to evaluate this 
clinical service as it was designed; some iterative changes were made over time, but these did not 
change the fundamental therapeutic objectives of the course. The intervention group is co-
facilitated by a PWP and a clinical nurse specialist from the medical oncology team. The course 
delivery is supervised by a clinical psychologist. On design of the service (and research study) the 
intervention was intended to be delivered over six weekly sessions, however, from group two 
onwards, the content was spread out to include an additional week with an eighth week added as a 
wrap-up and review with no new content.  
For this trial, the intervention was compared to a treatment-as-usual control group. Participants in 
this group received no additional intervention other than their standard clinical care and a weekly 






Eligibility criteria and sample size 
Participants were women over 16 years of age who had completed first-line treatment following a 
gynaecological cancer diagnosis. We excluded those expected not to survive for the full five-month 
duration of the study (to mitigate against distress), those not fluent in English, and those unable to 
give informed consent.  
Our sample size calculation was based on our original study aims of comparing between-group 
intervention effectiveness. To adequately power a two-arm experimental comparison (1-β = .90; α = 
.95; nine time-points) would have required ten participants per group to detect a medium 
interaction effect size f = .25 (medium effect size are indicated by NICE [39] as being necessary for 
clinical significance in the case of depression-related outcomes), though given that medium effect 
sizes are uncommon in psychosocial oncology intervention research we planned to recruit in excess 
of this. 
Recruitment 
At our intervention-delivery site, patients either self-referred or were informed about the availability 
of the intervention following completion of first line-treatment by their clinicians using an 
information sheet. There was no distress screening: all patients accessing the service were offered 
the chance to join the intervention if they wanted to. Those identified as highly distressed were, 
however, offered additional one-to-one psychological support as part of stepped-care service 
provision [40]. On setting up the service, the expectation was that four or five intervention groups 
would run each year, each with up to 15 participants per group. We expected that rates of consent 
for data to be used in our study would be relatively high, and therefore that we would be able to 
recruit 35-40 participants in a twelve-month period. 
At the control sites (two general hospitals in North Wales), eligible participants were identified by 
clinical teams as part of routine weekly multidisciplinary team meetings. They were then invited to 
participate by their oncologist or specialist nurse. For this group we included patients prospectively 
diagnosed through the recruitment period, but also any retrospectively identified who had 
completed first-line treatment within a period of four months from the start of the study: this was 
comparable with the intervention group given that the intervention was planned to be delivered just 
four times per year, thus introducing delay between completing treatment and accessing the 
intervention. A recent review suggested that with clinician approach we could expect around 70-80% 
participation rates [41], though this is likely to reduce over time due to participant attrition. Our 
intention was to recruit 100 participants to this group (a) to provide a more representative 
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description of unmet needs in this group, and (b) to enable extraction of a sub-set of participants 
with similar distress profiles at baseline to the intervention group for matched analysis.  For various 
logistic reasons we were restricted to recruiting our control sample for just a six-month period.  
Data collection and measures 
All participants completed self-reported outcome assessments at baseline (pre-intervention), and 
then weekly for seven subsequent weeks: this was intended to map onto data collection at each 
week of the intervention delivery, plus a one-week follow-up. From the second delivery iteration of 
the CBT group, however, an extra two weeks were added to the CBT programme. Given that (a) the 
majority of our control group data collection was already collected by this point, and (b) the new 
‘week eight session’ was a review and wrap-up session only, we did not consider it hugely 
problematic that this was delivered after our final data collection point: our post-intervention data 
collection point thus remained at Week 7, which in essence became the final week of delivery in the 
review programme. The three-month follow-up data was collected via telephone interview 
conducted by the intervention delivery team. All data for control-arm participants was collected via 
telephone-based structured interviews at identical time-points to the intervention arm. Patients 
reported on their own socio-demographic profile. Basic diagnosis and treatment information was 
provided by the clinical teams, with participant consent. 
Primary outcomes 
Depression. The Patient Health Questionnaire (PHQ-9) [42] is a nine-item tool which uses a four-
point rating scale (ranging from 0 to 3) to ask how often in the last two weeks participants have 
experienced symptoms pertaining to appetite, concentration, energy hopelessness, and suicidality. 
Higher scores indicate higher levels of depression. The PHQ-9 has been established as a valid and 
reliable measure of depression severity [42], and recent work has established it as a sensitive 
assessment tool for cancer-related distress [43].  
Anxiety. The Generalized Anxiety Disorder questionnaire (GAD-7) [44] is a seven-item screening tool 
to how often in the last two weeks participants have experienced symptoms pertaining to feeling 
anxious, worried, had difficulty relaxing, and irritability. The GAD-7 uses a four-point rating scale 
(ranging from 0 to 3) and higher scores indicate higher anxiety. The GAD-7 has been established as 
an accurate measure of [45], including specifically within psychosocial oncology research [46].  
Both the GAD-7 and the PHQ-9 were included as they form part of the minimum data set required 





Quality of Life. The Functional Assessment of Cancer Therapy-General (FACT-G) is a 33-item tool 
commonly used to assess quality-of-life in patients receiving cancer treatment [47]. The FACT-G uses 
a five-point rating scale (ranging from 0 to 4) asking how often in the last seven days difficulties have 
been experienced across four dimensions of wellbeing: physical; social/family; emotional; functional. 
Higher scores indicate lower quality-of-life. The FACT-G is a well validated tool for measuring quality-
of-life in cancer sample [48].  
Unmet needs. The Short-Form Supportive Care Needs Survey (SCNS SF-34) [49] is a 34-item survey to 
assess level of unmet needs across five separate domains: psychological needs; sexuality needs; 
health system and information needs; physical daily needs; and, care and support needs. The SCNS 
SF-34 uses a five-point rating scale (ranging from 1 to 5) asking how often in the last month patients 
have required help across each of these unmet needs items. 
Therapeutic process measures 
To evaluate potential intervention mediators, we assessed variables that we expected might be 
changed by a psychological treatment protocol. To reduce participant burden these were assessed at 
baseline, post-intervention and follow-up only. 
Thought intrusion.  The Impact of Events Scale-Revised (IES-R) [50] is a 22-item measure of thought 
intrusion following a traumatic event. The IES-R uses a five-point rating scale (ranging from 0 to 4) 
asking how often in the past week patients have experienced stress reactions after traumatic life 
events. This is a valid and reliable measure of stress responses in different populations [51]. We used 
the thought intrusion sub-scale of the IES-R to measure whether the intervention has reduced the 
occurrence of problematic cognitions, as would be expected in CBT [52]. 
Self-efficacy. Psycho-educational component of the intervention were expected to increase 
participants’ perceptions of their ability to self-manage the long-term consequences of their cancer 
and treatment. We assessed this using an 11-item cancer specific self-management self-efficacy 
scale [53,54] which is an adaptation of the Self-Efficacy for Managing Chronic Disease Scale [55], a 
widely used and well-validated measure. Each item requests a response using a 10-point scale 
(ranging from 1, not at all confident, to 10, totally confident). The adapted scale for cancer survivors 
has good reliability and psychometric properties [53]. 
Psychological flexibility. Given that the intervention content drew upon themes from third-wave 
interventions in addition to traditional CBT, we assessed sub-components of psychological flexibility 
(openness to experience, behavioural awareness, valued action) using the Comprehensive 
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Assessment of Acceptance and Commitment Therapy processes (CompACT) [56]. The CompACT is a 
23-item measure which demonstrates good internal consistency across all three scoring clusters 
[56]; high scores indicate greater psychological inflexibility. 
Statistical analyses 
Analysis was undertaken using SPSS v24. All data were cleaned, recoded and reverse-scored as 
needed using standard scoring procedures. Where there was less than 10% missing data on self-
report variables, mean-score imputation was used. Standard checks for data normality (box plot 
visual graphs and Shapiro Wilk test of sampling distributions), and sample size determinations, were 
used to determine whether parametric or non-parametric tests should be used.  
Information on recruitment, response and attrition are reported descriptively so as to provide a 
narrative on the success (or lack thereof) of the study design. Baseline differences in these variables 
between the intervention and control group were explored using Mann Whitney U tests.  
Our sample size was small, and our data were underpowered, but we nonetheless explored some 
preliminary analyses of our stated study aims. Our primary aim — intervention effectiveness on 
depression and anxiety — was addressed using 2 by 2 mixed ANOVAs (exploring changes from 
baseline to post-intervention between condition) and 2 by 3 mixed ANOVAs (exploring changes from 
baseline to post-intervention and follow-up between conditions). Secondary outcomes were also 
analysed using ANOVAs. Mediation analyses of therapeutic process variables on intervention 
outcomes was not possible due to limited sample sizes.  We therefore used ANOVAs to explore 
differences between conditions and over-time in these variables instead.  
 
Results 
After extending our recruitment period to last almost two years (Recruitment: May 2018 to February 
2020; Follow-up period closed in May 2020), we closed recruitment having fallen considerably short 
of our recruitment targets (see Figure 1). Sign-up for the intervention group was far lower than had 
been expected, and so fewer intervention groups were run. In total, just eight patients had taken 
part in one of three iterations of the CBT group. Of these eight, six consented for their data to be 
used in the study representing a 75% response rate. At our control site, just 26 participants 
consented to take part; this was a result of both (a) staff sickness at one site leading a period of non-
recruitment, and (b) actual diagnosis rates being far lower than had originally been estimated by the 
local clinical teams. Over our recruitment period, 51 new patients were diagnosed; 36 of these met 
eligibility criteria (71% eligibility rate), and of those 26 consented for the study (72% consent rate). 
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Although this fell short of our recruitment target (for both groups) it was not possible to keep 
recruitment open indefinitely; funding to support data collection in North Wales had run out, and 
due to service re-organisation the group-based intervention in East Anglia was no longer going to be 
offered as standard care. We thus made the difficult decision to close the study short of target and 
disseminate our lessons learned (which this paper aims to do). In this context, we decided to 
conduct a more basic comparison of groups rather than adopting a matched-sample comparison as 
had been originally planned. 
***ADD FIGURE 1 ABOUT HERE*** 
In the CBT group, only one participant completed all sessions and the follow-up. Two participants 
had sporadic completion of the intervention across all weeks; another participant did not attend 
Week 5; another missed Week 2 and did not complete follow-up; and two participants missed 
Weeks 3 and 4, but then resumed participation thereafter. One participant dropped out entirely 
from Week 4 onwards (overall attrition to follow-up = 16%; see Figure 1).  
In the control group, six participants did not complete Week 2; four did not complete Week 3; three 
did not complete Week 4; three did not complete Week 5; six did not complete Week 6; and eight 
did not complete follow-up. No participant who completed baseline officially dropped out of the 
study (overall attrition to follow-up = 35%).  
Sample description  
Table 1 summarises key demographic and clinical characteristics of participants. There are some 
notable differences between the two groups; specifically, the control group were older and 
therefore more likely to be retired. The majority of our sample (both groups) were white and 
identified as heterosexual. The control group reported having received less support from local 
psychology or Macmillan services but this is perhaps because intervention group participants were 
informed about the study by the dedicated Macmillan-funded service that they were already 
engaged with. The sample was dominated by participants with ovarian cancer but this did not differ 
between groups and is representative of the broader gynaecological cancer population. The majority 
of participants had been diagnosed with Stage 3 cancer, though there was variation in diagnostic 
staging in both groups. All participants in the CBT group had received treatment with curative intent, 
whereas some participants in the control group had been treated with palliative intent. The majority 
of participants had been treated with either surgery alone, or surgery plus chemotherapy.  




Primary outcome: depression and anxiety  
Participants in the CBT group had higher mean scores on both depression and anxiety than the 
control group at baseline, with the difference in anxiety reaching statistical significance (p=.03; see 
Table 2). Scores decreased to both post-intervention and follow-up in both groups, and we note they 
are higher in control group at post-treatment compared to those who received the intervention. As 
an assumption check for ANOVA tests, Levene’s tests for homogeneity of variance (taken from the 
2*3 ANOVAs) demonstrated that the assumption of equal variances between groups was not 
violated for either depression (baseline, p = .157; post-treatment, p = .449; follow-up, p = .907) or 
anxiety (baseline, p = .844; post-treatment, p = .440; follow-up, p = .605).   
***INSERT TABLE 2 ABOUT HERE*** 
For depression, comparing only baseline to post-intervention changes, we found a significant main 
effect of time (F[1, 27] = 13.43, p = .001, n2par = .33), but a non-significant main effect of condition 
(F[1,27] = .63, p = .435, n2par = .02) and a non-significant time by condition interaction effect (F[1, 27] 
= 2.44, p = .130, n2par = .08). Using a 3*2 ANOVA which also incorporated follow-up scores, neither 
the main effect of time (F[2, 34] = 1.99, p = .152, n2par = .11), or condition (F[1,17] = .60, p = .45, n2par 
= .03), nor a time by condition interaction (F[2, 34] = .03, p = .973, n2par = .00) reached significance.  
Similarly, for anxiety, comparing baseline to post-intervention scores, our data show a significant 
main effect of time (F[1, 25] = 15.854, p = .001, n2par = .39), but non-significant main effects of 
condition (F[1, 24] = .409, p = .528, n2par = .02) and time by condition interaction (F[1, 25] = 5.84, p = 
.023, n2par = .19). Extending this to include follow-up data (comparing baseline, post and follow-up) 
resulted in the main effect of time remaining significant (F[2, 34] = 11.07, p < .001, n2par = .39) and 
additional significant differences emerging for main effects of condition (F[1,17] = .21.12, p < .001, 
n2par = .56) and time by condition interaction (F[2, 34] = 3.51, p = .04, n2par = .17). 
Secondary outcomes: quality of life and unmet needs 
Participants in the CBT group had lower mean scores on quality of life at baseline and at post-
intervention than those in the control condition. Mean scores were roughly equivalent at follow-up 
for both groups. Levene’s tests for homogeneity of variance demonstrated that the equal variances 
assumption was violated for quality of life at baseline (p = .034) and follow-up (p = .044) (2*2 model 
only). 
Baseline to post-intervention change in quality of life failed to reach significance for main effects of 
time (F[1, 27] = .28, p = .600, n2par = .01),  condition (F[1, 7] = .21, p = .635, n2par = .01) or time by 
condition interaction (F[1, 27] = .04, p = .847, n2par = .00). Including follow-up data failed to improve 
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these findings: no main effects of time (F[2, 24] = .29, p = .749, n2par = .02), condition (F[1, 12] = .60, p 
= .453, n2par = .05), or time by condition interaction (F[2, 24] = .78, p = .472, n2par = .06) effects 
reached significant. However, these latter results should be interpreted with caution given that 
there were only 2 participants in the CBT group and 12 participants in the control group. 
Moderate to high needs were defined as a score of four or five on each item of the SCNS-SF34, with 
a score less than three indicating no need at present. Regardless of group allocation, all participants 
had at least one moderate-to-high need in the patient care and support needs domain. The highest 
rated need was ‘Reassurance by medical staff that the way you feel is normal’ for the CBT group 
participants, and ‘Hospital staff attending promptly to your physical needs’ for the control group. 
Given the small sample size and some violations of normality on these variables, we were unable to 
run parametric statistical analysis; instead, Mann-Whitney U test confirmed that there were no 
differences between group on overall domain scores of psychological needs, sexuality needs, health 
system and information needs, physical daily needs or care and support needs (Table 2). Unmet 
needs reduced over time for both groups, and in all domains. A 2*2 ANOVA on total needs score 
demonstrated a significant main effect of time (F[1, 19] = 7.9, p = .011, n2par = .29), but non-
significant main effects of condition (F[1, 19] = .07, p = .799, n2par = .00) and time by condition 
interaction effect (F[1, 19] = .11, p = .109, n2par = .01). 
Intervention mediator variables 
Due to our limited sample size, we were unable to undertake statistical analysis of potential 
therapeutic process as outcome mediator variables. At baseline, thought intrusion was higher in the 
CBT group and cancer-specific self-management self-efficacy was higher in the control group. At 
baseline, the CBT group also scored higher in overall psychological flexibility and sub-scale scores of 
behavioural activation and value-action; interestingly, however, our control group scored as more 
inflexible on the openness to experience subscale.  By follow-up, between group differences had 
minimised with the CBT group reducing in intrusive thoughts, increasing in self-management self-
efficacy and reduced psychological inflexibility, though there was high variance on each, as indicated 
by large standard deviations.  
Two-by-two mixed ANOVAs were run to explore between group differences in score changes from 
baseline to follow-up (Table 3). These demonstrate no significant main effects or interaction effects 
for thought intrusion. A significant main effect of time was found for self-management self-efficacy, 
and whilst the main effect of condition failed to reach significance, the time by condition interaction 
was significant. For psychological inflexibility (total score), there was only a significant main effect of 
time only.  
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Discussion 
With the potential for the benefit of psychological intervention on distress and quality of life in 
cancer so readily acknowledged [13, 57], research that expands the evidence both in terms of 
efficacy and readily implementable interventions is needed. Given the importance of cost-
effectiveness [24], group-based, low-intensity interventions are attractive, and the growing role of 
Psychological Wellbeing Practitioners (PWPs) in managing the psychological effects of chronic health 
conditions in the UK offers an obvious route through which to test the feasibility of these types of 
interventions. The study, therefore, aimed to explore the effectiveness of a PWP co-facilitated, 
group-based, psychological intervention for improving depression and anxiety in women treated for 
gynaecological cancer. As secondary aims, we wanted to explore intervention effects on quality of 
life and unmet needs, and to identify potential psychotherapeutic mediators of intervention 
outcomes.  
Effectiveness of the intervention 
A series of practical issues resulted in low recruitment and so our data was not sufficiently powered 
to address any of these aims conclusively. Nonetheless, there are some interesting patterns in the 
data. Baseline scores of anxiety and depression were higher in the intervention group; this is not 
surprising given that they had presented for additional psychological support, compared to our 
control group which was a population snapshot. Of importance, this probably reinforces the idea 
that not all cancer survivors suffer with problematic levels of psychological distress, and even in 
those that do, only a small minority will want this to be addressed with a formal psychology-based 
[58].  Depression improved over time in all participants however, no between-group differences 
were identified. Anxiety, in comparison, showed more intervention benefits with significant 
between-group differences emerging from baseline to follow-up. It is possible that the lack of 
statistical power is masking the true effectiveness of the intervention, but as they stand, these data 
suggest that the intervention might be more effective for anxiety outcomes than it is on targeting 
improvements in depression. Such a difference might not be surprising given the different causal 
factors that may be at play in the development of these distress components in cancer [59], and thus 
the different intervention strategies that might be needed.  
The most frequently endorsed unmet needs in our sample were those in the ‘Patient Care and 
Support’ domain. This is in contrast to other studies that suggests that psychological and sexuality 
needs are more prominent in this survivor group [10,11]. Unmet needs reduced over time in both 
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groups as might be expected as part of the natural adaptation process at the end of treatment, but 
we identified no additional intervention effects on this speed or extent of this improvement. 
There is a paucity of research investigating potential psychological mediators in cancer survivors 
[15], therefore the EPELIT study was designed to also explore potential mediators. This is important: 
where the most effective mediators can be identified, intervention content can be refined to 
maximise change on these process variables, to consequently maximise improvements in desired 
outcome variables. We urge caution interpreting the results of changes in putative 
psychotherapeutic mediators from our study, however we are encouraged by the significant time by 
condition interaction for self-management self-efficacy. Given the literature elsewhere on self-
management self-efficacy as a useful coping and adaptive skill [54], it is possible that this might have 
accounted for some of the improvement in anxiety in our sample. Further work to test this in larger, 
more powered samples, is now needed.  
Although we did not collect data on intervention acceptability, this is clearly of interest given the 
novel facilitation method of this intervention, such as the use of a PWP intervention facilitation. 
Drop-out from psychological interventions can be a useful proxy indicator of acceptability and to this 
end, the data from this study are encouraging and suggest that CBT remains an acceptable 
intervention framework for this group [15], and that delivery by a team including PWPs was not off-
putting to those who agreed to participate.  
Study evaluation and methodological discussion 
Though our participant numbers were low, response rates were encouraging. Because study 
invitation was provided by a known member of the clinical care team, we had expected around a 70-
80% participation rate [41], and our study data bear this out: we achieved 72 and 75% participation 
rates in the control and intervention group respectively. Retention to follow-up was also good with 
attrition of just 16% in the intervention group and a higher, but still non-problematic, 35% in the 
control group. Our failure to successfully recruit was not, therefore, a problem of consent or 
retention, but rather one of baseline population size: at our control site, the number of new 
diagnosis was just one third of the number that we had been led to expect on designing the trial, 
and at the intervention site far fewer participants were referred (or self-referred) to this 
intervention than had been expected, falling short of expectations by a factor of four. To further 
clarify, we even collected data on the reasons that patients at each site might not have been 
recruited. These data show that this was most definitely not an issue of high levels of ineligibility: all 
those presenting for the intervention group were eligible for the study and 71% of all new patients 
diagnosed at the control site were eligible and approached. There were some demographic and 
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clinical biases in our sample, but these are representative of the clinical and demographic population 
from which we recruited. Nonetheless, efforts to recruit a more demographically diverse sample in 
future research would be welcomed as a way to expand the overall evidence-base in psychosocial 
oncology [15]. 
In this way, perhaps paradoxically, the greatest strength of our study design was also the greatest 
weakness. We selected a pragmatic non-randomised trial design for this study with both practical 
and ethical considerations in mind; these kinds of design are becoming more and more popular in 
clinical care research because they provide a way for existing services to be evaluated against a 
control group, without the ethical concerns of having to withhold a potentially beneficial 
intervention to which all patients should have access from the control group. It was, however, this 
design which led to the ultimate failure of the study: existing services, by their very design, have to 
be responsive to the populations that they serve, are subject to changes in staffing, funding and 
commissioning, and so iterative changes are to be expected over time. In our case, some of these 
changes introduced unexpected methodological challenges and potential bias.  
We became aware that some of the intervention content and order was modified followed a change 
in staffing part-way through the study. Though this was not intended to change any of the 
fundamental psychotherapeutic goals of the intervention, changing content in this way may 
potentially have changed the macro-level focus of different underlying psychotherapeutic process. 
Had we recruited to target this would have undoubtedly made analysis of mediator data incredibly 
complex, if not entirely uninterpretable. Again, whilst understandable from a service-delivery 
perspective, this can have profound consequences on the methodological validity of aligned 
effectiveness trials.  
Relatedly, with our post-intervention data point scheduled for week seven (one week after the close 
of the original design of the group intervention) this change to the intervention programme meant 
that for those participating in the study after this change, the post-intervention questionnaire 
assessment was completed after receiving only 75% of the intervention sessions. Our trial steering 
group made the decision not to change the timing of this data collection point given that a 
considerable number of control-group participants had already been recruited and this would have 
rendered their data non-comparable. Given variance in exact completion time of longer-term follow-
up across the literature, we do not anticipate that this change would have affected our final three-
month follow-up data, but it may well have affected earlier time-points. This highlights the 
challenges of evaluating existing services which have to be responsive to local clinical need, and the 
potential benefits of testing these kinds of research questions using an ‘additive’ model where more 
research control is retained over intervention content and delivery. 
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As a final important critical note, we would add that psychosocial research is often limited because 
the outcomes to which we are most interested are burdensome to measure. Unlike disease-oriented 
outcomes such as number of participants who experienced disease recurrence or survival, outcomes 
such as distress and quality of life are subjective, and thus require assessment using patient-
reported measures. These measurement tools can feel burdensome and so we often attempt to 
minimise the length and number of administrations when designing studies; indeed, this is a 
common concern of ethical review committees. To investigate intervention mediators effectively, 
however, regular assessments are important; an important secondary research question in our 
study, therefore, was to establish the willingness of participants to report on these variables on a 
weekly basis. To this end, our study was a partial success: though we report 35% follow-up attrition, 
our discussions with participants indicated that a vast majority of these missing data points were 
about scheduling difficulties more than they were about participation fatigue. This is an important 
learning point from our work which demonstrates that we should not necessarily be quite so 
avoidant of higher-burden data collection protocols in our trial research.  
Implications and future research 
Some implications from this study are somewhat obvious: because of recruitment issues, our study 
failed to answer conclusively whether (a) CBT-based interventions are helpful in improving 
psychological wellbeing and (b) whether psychological wellbeing practitioner facilitation is an 
effective delivery mechanism. Future research to address these important research questions is still 
very much needed, but a more traditional approach using a randomised controlled trial independent 
of usual care might be a more effective study design. 
Of perhaps greater concern: whilst smaller than in some comparison cancer groups, increasing 
survivorship within gynaecological cancer means that far more women are living after treatment for 
this kind of cancer over time [2] and previous research demonstrates that unmet psychological and 
physical needs often remain high [60]. Recruitment into these intervention groups should, therefore, 
have been simple. Our study failed to recruit, not because women attending the groups did not 
consent to be part of the trial, but simply because the intervention groups themselves failed to 
recruit. Work is needed, therefore, to understand why those with high needs are not presenting for 
this kind of psychological support: qualitative studies on the barriers to attendance or why this 
particular offering was unappealing would be helpful. Indeed, the future design of such 
interventions might benefit from using a co-design method of production [61] to ensure that what is 





This trial did not go to plan: although indications are that the intervention was acceptable and 
potentially helpful, recruitment was incredibly challenging and the iterative nature of development 
of the intervention rendered concrete conclusions impossible. Whilst we have demonstrated the 
success of some of our methodological choices (e.g. frequent data collection for designs intended to 
explore mediation), our overall design choice of employing a pragmatic trial design was not 
appropriate because of the lack of control we had over both recruitment and changes to 
intervention content. This has important implications for future research in psychosocial oncology; 
whilst pragmatic trials might be appropriate for later-stage implementation research, we found 
them to be fraught with methodological challenges for earlier-stage effectiveness trials and would 
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Table 1. Description of demographic and clinical profile of participants. 
 CBT (n = 6) Control (n = 26) 
Age M (SD) 
 
44.50 (13.07) 68.81 (9.52) 
Dependents M (SD) 
 























Yes, living together 















































































































Treatment received  
Surgery only 
Surgery + chemotherapy 
Surgery + radiotherapy 

















Table 2. Means and standard deviations for each variable across groups and time.  




























U = 32.00, p = .030 













U = 61.50, p = .425 











U = 64.00, p = .499 











U = 50.50, p = .174 
 























U = 54.50, p = .256 











U = 69.50, p = .673 







U = 26.00, p = .012 
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U = 37.50, p = .050 






Table 3.  Results from mixed 2*2 ANOVAs for potential mediator variables.   
  df dferror F p n2pa M (SD) Control  M (SD) CBT 























































































Figure 1. Flow chart of intervention and control group at each stage of the study.   
 
 
 
 
